3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Leiomyoma
4
Menorrhagia
2
Interventions
estradiol, norethindrone drug combination
9
elagolix
7
Estradiol
7
asoprisnil
6
relugolix
5
Norethindrone Acetate
5
vilaprisan
4
Uterine Myomectomy
3
linzagolix
2
Uterine Artery Embolization
2
ulipristal
1
Radiofrequency Ablation
1
Progesterone
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Electrocoagulation
1
Cryosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Menorrhagia
×
linzagolix
×
Clear all
NCT03070899
2021-06-09
PRIMROSE 1
ObsEva SA
Phase 3
Completed
526 enrolled
NCT03070951
2021-03-05
PRIMROSE 2
ObsEva SA
Phase 3
Completed
511 enrolled